Mode
Text Size
Log in / Sign up
N/A Completed N=72 Randomized Single-blind Treatment

iAssist vs. Conventional Instrumentation in Total Knee Arthroplasty

Avascular Necrosis · Post-traumatic; Arthrosis · Knee Osteoarthritis
Source: ClinicalTrials.gov NCT03111407 ↗
Enrolled (actual)
72
Serious AEs
8.3%
Results posted
Apr 2021
Primary outcomePrimary: Component Alignment — 179; 178 degree — p=0.2342

Summary

The purpose of this prospective study is to evaluate Zimmer® iASSIST™ with respect to radiographic, clinical and economic outcomes and compared to conventional instrumentation in primary total knee arthroplasty (NexGen or Persona knee implants).

Outcome Measures

OutcomeResultp-value
PRIMARY
Component Alignment
179; 178 0.2342
SECONDARY
Knee Society Score Assessment
74.7; 72.4 0.4427
SECONDARY
Knee Society Score Function
80.5; 78.5 0.6154
SECONDARY
EQ-5D Questionnaire
0.8; 0.8 0.4549

Eligibility Criteria

Inclusion Criteria

  • Patient is male or female
  • Patient needs a primary total knee replacement using the NexGen LPS Flex or Persona knee implant
  • Patient is diagnosed with non-inflammatory degenerative joint disease (e.g., osteoarthritis, post-traumatic arthritis, avascular necrosis, etc.)
  • Patient is over 18 years old
  • Patient is able to:
  • Understand what participation in the study entails and willing to consent (patient or his/her legal guardian) to participate in the study by signing and dating an IRB/EC (ethics committee) approved inform consent form, and
  • Follow surgeon/staff instructions, and
  • Return for all follow-up evaluations, and
  • Able and willing to undergo a preoperative full-leg, standing radiographs and/or CT-scan
  • Patient meets an acceptable preoperative medical clearance and is free of or treated for cardiac, pulmonary, hematological or other conditions that would pose excessive operative risk.
  • Patient has a presence of varus or valgus deformity of 15 degrees or less.

Exclusion Criteria

  • Patient is currently enrolled in an investigational new drug or device study.
  • Patient has an active infection (including septic knee, distant infection, or osteomyelitis).
  • Patient has severe hip arthrosis.
  • Patient has neurological disorders (including, but not limited to Parkinson's disease).
  • Patient has had a prior ipsilateral unicompartmental knee arthroplasty, TKA, knee fusion or patellectomy.
  • Patient has hip or knee ankylosis.
  • Patient has inflammatory joint disease.
  • Patient has rheumatoid knee arthritis.
  • Patient has indications of intra- and/or extra-articular deformations that would eliminate or tend to eliminate adequate implant support or prevent the use of an appropriately sized implant, such as polio, history of tibial plateau fracture, etc.
  • Patient has any metal within 150 mm of the joint line for the operative-side knee.
  • Patient has knee deformities greater than 15 degrees of fixed varus, valgus, or flexion contracture on initial physical examination.
  • Female who is pregnant or lactating.
  • Patient currently involved in any personal injury litigation, medical-legal or worker's compensation claims.
  • Patient has arterial disease or stents that would exclude the use of a tourniquet.
  • Patient has insufficient quality or quantity of bone to support the implant due to prior knee surgery (or surgeries), cancer, metabolic bone disease, osteoporosis/osteopenia (diagnosed or treated with medication), active/old/remote infection, etc.
  • Patient has a mental condition that may interfere with his/her ability to give an informed consent or interfere with his/her ability or willingness to fulfill the requirements of the study.
  • Patient has a condition that would place excessive demands on the implant (e.g., Charcot's joints, muscle deficiencies, multiple joint disabilities, skeletal immaturity, etc.).
  • Patient has collateral ligament insufficiency.
  • Patient has an immunosuppressive disorder (e.g., AIDS, etc.) that would require cytotoxic drugs, corticosteroids, large dose of irradiation, or antilymphocytic serum.
  • Patient has an existing condition that would, in the opinion of the investigator, compromise participation or follow-up in this study.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03111407). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search